Business

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

The results could pave the way for Pfizer’s drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia. 

Previous post Berkshire’s stock hasn’t skidded for this long in 15 years. What’s stalling it?
Next post DirecTV, Disney reach deal to end blackout in time for college football

More Stories